Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

Moreira 2013.

Notes Title: Prognostic value of interim vs. end‐of‐treatment PET scan in Hodgkin's lymphoma.
(Confernece abstract)
Aim

  • To evaluate the prognostic value of interim PET scan (PET2) and end‐of‐treatment PET (PET6) in the outcome of individuals with HL


Study design

  • Retrospective, January 2004 to December 2011


Country/treatment centre(s)

  • Portugal (Porto, single‐centre)


Number of included participants

  • 261


Inclusion criteria

  • Diagnosed HL


Exclusion criteria

  • PET‐guided treatment adaptation


Treatment

  • ABVD, BEACOPPesc or CVP/CEB


Primary outcome measure(s)

  • Complete remission

  • Overall survival

  • Progression‐free survival